Cite
Depot medroxyprogesterone acetate (DMPA) enhances susceptibility and increases the window of vulnerability to HIV-1 in humanized mice.
MLA
Wessels, Jocelyn M., et al. “Depot Medroxyprogesterone Acetate (DMPA) Enhances Susceptibility and Increases the Window of Vulnerability to HIV-1 in Humanized Mice.” Scientific Reports, vol. 11, no. 1, Feb. 2021, p. 3894. EBSCOhost, https://doi.org/10.1038/s41598-021-83242-9.
APA
Wessels, J. M., Nguyen, P. V., Vitali, D., Mueller, K., Vahedi, F., Felker, A. M., Dupont, H. A., Bagri, P., Verschoor, C. P., Deshiere, A., Mazzulli, T., Tremblay, M. J., Ashkar, A. A., & Kaushic, C. (2021). Depot medroxyprogesterone acetate (DMPA) enhances susceptibility and increases the window of vulnerability to HIV-1 in humanized mice. Scientific Reports, 11(1), 3894. https://doi.org/10.1038/s41598-021-83242-9
Chicago
Wessels, Jocelyn M, Philip V Nguyen, Danielle Vitali, Kristen Mueller, Fatemeh Vahedi, Allison M Felker, Haley A Dupont, et al. 2021. “Depot Medroxyprogesterone Acetate (DMPA) Enhances Susceptibility and Increases the Window of Vulnerability to HIV-1 in Humanized Mice.” Scientific Reports 11 (1): 3894. doi:10.1038/s41598-021-83242-9.